Evidence map›Paper›PMID 34986407›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

SARS-CoV-2 infection in children in Moscow in 2020: clinical features and impact on circulation of other respiratory viruses: SARS-CoV-2 infection in children in Moscow in 2020.

Alexander S Yakovlev, Ilmira K Belyaletdinova, Lyudmila N Mazankova, Elmira R Samitova, Ismail M Osmanov, Nataly V Gavelya, Viktor P Volok, Ekaterina S Kolpakova, Anna A Shishova, Natalia A Dracheva and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Alexander S YakovlevChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia. Electronic address: alex-montreal@yandex.ru.
Ilmira K BelyaletdinovaChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia. Electronic address: belyaletdinova_i@mail.ru.
Lyudmila N MazankovaRussian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, 125993, Russia; Z.A. Bashlyaeva Children's Municipal Clinical Hospital, Moscow, 125373, Russia. Electronic address: mazankova@list.ru.
Elmira R SamitovaRussian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, 125993, Russia; Z.A. Bashlyaeva Children's Municipal Clinical Hospital, Moscow, 125373, Russia. Electronic address: samitova_rudn@mail.ru.
Ismail M OsmanovZ.A. Bashlyaeva Children's Municipal Clinical Hospital, Moscow, 125373, Russia. Electronic address: osmanovim@zdrav.mos.ru.
Nataly V GavelyaZ.A. Bashlyaeva Children's Municipal Clinical Hospital, Moscow, 125373, Russia.
Viktor P VolokChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia; Department of Biology, Lomonosov Moscow State University, Moscow, 119991, Russia. Electronic address: viktor.p.v@mail.ru.
Ekaterina S KolpakovaChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia; Institute of Translational Medicine and Biotechnology, Sechenov Moscow State Medical University, Moscow, 119991, Russia. Electronic address: katerina.kolp@gmail.com.
Anna A ShishovaChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia; Institute of Translational Medicine and Biotechnology, Sechenov Moscow State Medical University, Moscow, 119991, Russia. Electronic address: a_shishova@list.ru.
Natalia A DrachevaRussian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, 125993, Russia.
Liubov I KozlovskayaChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia; Institute of Translational Medicine and Biotechnology, Sechenov Moscow State Medical University, Moscow, 119991, Russia. Electronic address: lubov_i_k@mail.ru.
Galina G KarganovaChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia; Department of Biology, Lomonosov Moscow State University, Moscow, 119991, Russia; Institute of Translational Medicine and Biotechnology, Sechenov Moscow State Medical University, Moscow, 119991, Russia. Electronic address: karganova@bk.ru.
Aydar A IshmukhametovChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russia; Institute of Translational Medicine and Biotechnology, Sechenov Moscow State Medical University, Moscow, 119991, Russia. Electronic address: ishmukhametov@chumakovs.su.
Russian Academy of Sciences · RURussian Medical Academy of Continuous Professional Education · RURussian Children's Clinical Hospital · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to estimate the impact of the COVID-19 pandemic on the circulation of non-SARS-CoV-2 respiratory viruses and the clinical characteristics of COVID-19 in hospitalized children.

methodsA total of 226 and 864 children admitted to the Children's City Clinical Hospital with acute respiratory infection in September to November of 2018 and 2020 in Moscow were tested for respiratory viruses using multiplex polymerase chain reaction (PCR) and Mycoplasma pneumoniae/Chlamydia pneumoniae using enzyme-linked immunosorbent assay.

resultsThe detection rate of non-SARS-CoV-2 viruses in 2020 was lower than in 2018, 16.9% versus 37.6%. An increase in the median age of children with respiratory viruses was observed during the pandemic (3 years vs 1 year). There was no significant difference in the frequency of intensive care unit (ICU) admission in children with SARS-CoV-2 and other respiratory virus infections (2.7% vs 2.9%). SARS-CoV-2 and human rhinoviruses, human metapneumoviruses, and human adenoviruses showed significantly lower than expected co-detection rates during co-circulation. An increase in body mass index (BMI) or bacterial coinfection leads to an increased risk of ICU admission and a longer duration of COVID-19 in children.

conclusionsThe COVID-19 pandemic led to significant changes in the epidemiological characteristics of non-SARS-CoV-2 respiratory viruses during the autumn peak of the 2020 pandemic, compared with the same period in 2018.

Indexed as

Adenoviruses, HumanCoinfectionCOVID-19ChildChild, PreschoolHumansMoscowPandemicsSARS-CoV-2ChildrenCOVID-19Molecular diagnosticsObesityRespiratory virusesSARS-CoV-2

Identifiers

PMID34986407
PMCPMC8720385
OpenAlexW4205565697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.